Search results
Q1 2024 CNO Financial Group Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoFirst time customers who are new to Medicare are most in need of the service and expertise provided...
3 common mistakes that could damage your retirement nest egg — and how to avoid them
AOL· 5 days agoThere are plenty of ways to save for retirement and pad your nest egg for those golden years. From 401(k) plans and Roth IRAs to health savings accounts and delayed Social Security benefits, ...
Medigap Policies Face New Federal Nondiscrimination Rule | ThinkAdvisor
ThinkAdvisor· 4 days agoThe U.S. Department of Health and Human Services is changing its strategy for regulating Medicare...
End of internet subsidy threatens telehealth access
Axios· 1 day agoThe federal aid program is seen as a key to improving health care access.
The 10 Trends and Legal Challenges We Are Tracking Throughout 2024
The National Law Review· 2 days agoFollowing the hearing, some senators called for assisted living facilities to be brought under the...
Centene Corporation (NYSE:CNC) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoCentene Corporation (NYSE:CNC) Q1 2024 Earnings Call Transcript April 26, 2024 Centene Corporation...
‘Are nursing homes our only option?’ These centers offer older adults an alternative.
Daily Montanan via Yahoo News· 4 days agoCHATTANOOGA, Tennessee — George Raines, a white-haired man in a red track suit and matching...
Solano Business Journal Spring 2024: Seven key retirement deadlines you will not want to miss
Fairfield-Suisun Daily Republic· 4 days agoYears before a typical retirement, key dates and deadlines pop up — things like being able to make...
Are Consumer Driven Health Plans the right FEHB plan for you?
Government Executive· 2 days agoConsumer Driven Health Plans or CDHPs have been around for a while, but we still get lots of...
Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
GuruFocus.com via Yahoo Finance· 2 days agoHe highlighted the broad population studied in the CABINET trial, which should make cabozantinib user-friendly and widely applicable across various subtypes of NET, enhancing its market adoption ...